SEHK:9966Biotechs
Assessing Alphamab Oncology (SEHK:9966) Valuation After A Mixed Period Of Share Price Returns
Key recent share performance
Alphamab Oncology (SEHK:9966) has drawn attention after a mixed share performance, with a gain over the past week and month that contrasts with negative moves over the past 3 months and year to date.
See our latest analysis for Alphamab Oncology.
The recent 7 day share price return of 15.9% and 30 day return of 15.16% off a HK$9.04 share price contrast with a weaker 90 day share price return of 11.37% and a mixed long term picture, with a 1 year total shareholder...